Product Information
SUCRALFATE 1 GM TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1830 per EA under NDC 00093221001. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
1 g/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093221001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SUCRALFATEApproval Type
Generic (ANDA)
FDA Application
ANDA070848On Market Since
11/11/1996
Pharmacological Classes
Price Statistics
The NADAC for SUCRALFATE 1 GM TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 13.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1830 per EA |
|---|---|
| All-time high | $0.2385 (May 10, 2017) |
| All-time low | $0.1563 (Nov 20, 2024) |
| 52-week high | $0.1905 |
| 52-week low | $0.1781 |
| Median price | $0.1992 |
| Average price | $0.1976 |
| Largest weekly change | +16.4% (Feb 22, 2017) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SUCRALFATE 1 GM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUCRALFATE 1 GM TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1830 per EA (NDC 00093221001), effective Jun 24, 2026.
How has the price of SUCRALFATE 1 GM TABLET changed over time?
Over the history we have for it, the NADAC for SUCRALFATE 1 GM TABLET has declined 13.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SUCRALFATE 1 GM TABLET?
Since Nov 28, 2013, the NADAC for SUCRALFATE 1 GM TABLET has ranged from a low of $0.1563 (Nov 20, 2024) to a high of $0.2385 (May 10, 2017), with a median of $0.1992 per EA.
Are there cheaper alternatives to SUCRALFATE 1 GM TABLET?
8 NADAC-published products share the same active ingredient, strength, and dosage form as SUCRALFATE 1 GM TABLET, but none are currently priced below it.
Who manufactures SUCRALFATE 1 GM TABLET?
SUCRALFATE 1 GM TABLET (NDC 00093221001) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.